Position in ALVO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$206,316
+$144,551 QoQ
Shares Held
60,151
+399.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Orion Porfolio Solutions, LLC holds $26,497,028 across 19 Drug Manufacturers - Specialty & Generic names. ALVO ranks #16 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
42,417 | $5,014,113 | |
| 2 | HLN |
Haleon plc
|
388,159 | $3,885,471 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
25,141 | $3,312,075 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
87,821 | $2,676,784 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4,240 | $2,514,234 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
97,313 | $1,802,235 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
17,206 | $1,305,074 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
50,786 | $1,215,308 |
All Filings in ALVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $206,316 | 60,151 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $61,765 | 12,040 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $92,301 | 11,270 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||